Last $46.38 USD
Change Today +0.13 / 0.28%
Volume 2.9M
GSK On Other Exchanges
Symbol
Exchange
Xetra
London
Mexico
Frankfurt
As of 6:40 PM 11/20/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by GLAXOSMITHKLINE PLC-SPON ADR (GSK) in the last 6 months

Announced 10/9/14
Aspen Japan K.K.
Merger/Acquisition

GlaxoSmithKline plc (LSE:GSK) entered into an agreement to acquire 25% stake in Aspen Japan K.K. from Aspen Global Incorporated on October 9, 2014. Completion of the agreement is subject to a number of conditions precedent one of which is Aspen Japan K.K. obtaining accreditation as a marketing authorisation holder from the relevant Japanese regulatory authority. The transaction is expected to close by the end of 2015. Richard Smith, Jeremy Chew, Claire Jackson, Susie ...
Read More


GSK's price was unchanged after the transaction was announced on 10/9/14.
Investor / Buyer
GlaxoSmithKline plc
Creditor / Lender
Aspen Global Incorporated
 
Announced 09/22/14
10.00M for Silarus Therapeutics, Inc.
Private Placement

Silarus Therapeutics, Inc. announced that it will receive $10 million in its series A round of funding from new investors Avalon Ventures, LLC and GlaxoSmithKline plc on September 22, 2014. The investors will acquire majority stake in the company.


GSK's price was unchanged after the transaction was announced on 09/22/14.
Investor / Buyer
Avalon Ventures, LLC
GlaxoSmithKline plc
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:US $46.38 USD +0.13

GSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $159.36 USD +0.53
AbbVie Inc $65.19 USD -0.31
Bayer AG €113.84 EUR +0.125
Celgene Corp $107.35 USD +0.37
Novo Nordisk A/S kr263.80 DKK -0.70
View Industry Companies
 

Industry Analysis

GSK

Industry Average

Valuation GSK Industry Range
Price/Earnings 16.6x
Price/Sales 2.9x
Price/Book 13.5x
Price/Cash Flow 16.5x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.